Cargando…

Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat in the liver. An international consensus panel has recently proposed to rename the disease to metabolic dysfunction associated with fatty liver disease (MAFLD). The disease can range from simple steatosis (fat accumulation) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamwal, Rohitash, Barlock, Benjamin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560175/ https://www.ncbi.nlm.nih.gov/pubmed/32872474 http://dx.doi.org/10.3390/ph13090222

Ejemplares similares

Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
por: Wang, Hao, et al.
Publicado: (2020)

Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
por: Preissner, Sarah C., et al.
Publicado: (2013)

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes
por: Raunio, Hannu, et al.
Publicado: (2015)

The cytochrome P450 (CYP) superfamily in cnidarians
por: Pankov, Kirill V., et al.
Publicado: (2021)

CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver
por: Rey-Bedon, Camilo, et al.
Publicado: (2022)

Effect of citral on mouse hepatic cytochrome P450 enzymes
por: Tang, Huaqiao, et al.
Publicado: (2018)

The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease
por: Schuck, Robert N., et al.
Publicado: (2014)

Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model
por: Kozaczek, Melisa, et al.
Publicado: (2021)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome
por: Sekretarska, Justyna, et al.
Publicado: (2019)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
por: Pedersen, Kata W., et al.
Publicado: (2021)

The cytochrome P450 (CYP) gene superfamily in Daphnia pulex
por: Baldwin, William S, et al.
Publicado: (2009)

Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes
por: Albassam, Ahmed A., et al.
Publicado: (2018)

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
por: Le, Thien-Kim, et al.
Publicado: (2022)

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
por: Preissner, Saskia, et al.
Publicado: (2010)

Bioactivation of Aromatic Amines by Human CYP2W1, An Orphan Cytochrome P450 Enzyme
por: Eun, Chang-Yong, et al.
Publicado: (2010)

Single-Walled Carbon Nanotubes Inhibit the Cytochrome P450 Enzyme, CYP3A4
por: El-Sayed, Ramy, et al.
Publicado: (2016)

Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes
por: Ung, Yee Tze, et al.
Publicado: (2018)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Regulation of the homeostasis of hepatic endoplasmic reticulum and cytochrome P450 enzymes by autophagy
por: Ma, Xiaowen, et al.
Publicado: (2018)

Modulatory effects of Benjakul extract on rat hepatic cytochrome P450 enzymes
por: Samuhasaneeto, Suchittra, et al.
Publicado: (2021)

Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
por: Gonzalez, Andrea, et al.
Publicado: (2020)

MutaCYP: Classification of missense mutations in human cytochromes P450
por: Fechter, Kenneth, et al.
Publicado: (2014)

Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023)

The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetes
por: Liu, Jinghan, et al.
Publicado: (2022)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
por: Wei, Jinlan, et al.
Publicado: (2018)

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
por: Zhang, Ning, et al.
Publicado: (2019)

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes
por: Dong, Gang, et al.
Publicado: (2018)

In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes
por: Liu, Lu, et al.
Publicado: (2017)

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
por: Zhang, Xunge, et al.
Publicado: (2020)

Identification of 74 cytochrome P450 genes and co-localized cytochrome P450 genes of the CYP2K, CYP5A, and CYP46A subfamilies in the mangrove killifish Kryptolebias marmoratus
por: Lee, Bo-Young, et al.
Publicado: (2018)

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
por: Solan, Megan E., et al.
Publicado: (2023)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
por: Singh, Shivaram P., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
por: Di Ciaula, Agostino, et al.
Publicado: (2021)

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
por: Fang, Tingyu, et al.
Publicado: (2022)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h9qos30ku7g7h11saa207o4buo